QNTM

DKS

Consumer Discretionarylarge cap
QNTM SCORE
29/100
LOW CONVICTION
top 94% of the universe

As of 2026-09-10, DKS scores 29out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. DKS trades at $133.14, within its fair-value band.

DKS scores 29 out of 100 on QNTM's five-factor model — a low-conviction reading — at 29 the factor profile is among the weaker names in the universe. Its strongest factor is volume at 53 (solid), where trading volume confirms genuine accumulation, followed by value at 49. The weakest is momentum at 8, where price trend is the soft spot. Among Consumer Discretionary stocks it sits in the lower 6% of Consumer Discretionary names by composite.

On valuation, DKS is priced near the floor of its own recent range — the cheap end on the model's valuation read. The blended composite before the macro overlay was 33. Same-sector names the model rates nearby include ANF, BBY, HRB.

This is a descriptive factor read on DKS, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where DKS sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum8
Quality42
Value49
Volume53
Sentiment28

VALUATION RANGE

QNTM’s descriptive fair-value band for DKS runs $119.10–$215.23. Current price $133.14 sits within its fair-value band. This is valuation context, not a price target.

See DKS update live, and set an alert when its conviction changes

QNTM rescores DKS and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER CONSUMER DISCRETIONARY NAMES

ANF58BBY56HRB55EXPE54FTDR52DUOL52SIG51LAUR51

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.